On May 25, 2022, MiMedx Group, Inc. announced that a proxy advisory firm Institutional Shareholder Services (ISS) has recommended that shareholders vote for all of the Company's proposals including for both of the Company director nominees – James L. Bierman and Phyllis Gardner, on the Company's proxy card at its 2022 annual meeting of shareholders scheduled for June 7, 2022, which would be held in virtual format at www.cesonlineservices.com/mdxg22_vm.